RAPT Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
RAPT Therapeutics has a total shareholder equity of $95.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $108.5M and $13.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$97.91m |
| Equity | US$95.51m |
| Total liabilities | US$12.96m |
| Total assets | US$108.47m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0RA's short term assets ($102.6M) exceed its short term liabilities ($10.4M).
Long Term Liabilities: 0RA's short term assets ($102.6M) exceed its long term liabilities ($2.6M).
Debt to Equity History and Analysis
Debt Level: 0RA is debt free.
Reducing Debt: 0RA has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0RA has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 0RA has sufficient cash runway for 1 years if free cash flow continues to reduce at historical rates of 22% each year.